A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases
Mohammad S. Eram(University of Toronto), Jian Jin(Icahn School of Medicine at Mount Sinai)
Cited by 290
Related Papers
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis
|Cancer Discovery|2020|73
Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53
|Journal of the American Chemical Society|2023|53
Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer
|Journal of Medicinal Chemistry|2023|50
Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2
|European Journal of Medicinal Chemistry|2024|36